Last reviewed · How we verify
Vehicle gel (SH H 655 PBA) — Competitive Intelligence Brief
phase 3
Topical formulation
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Vehicle gel (SH H 655 PBA) (Vehicle gel (SH H 655 PBA)) — LEO Pharma. Vehicle gel is a topical formulation used to deliver active pharmaceutical ingredients to the skin.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vehicle gel (SH H 655 PBA) TARGET | Vehicle gel (SH H 655 PBA) | LEO Pharma | phase 3 | Topical formulation | ||
| ACYC vehicle | ACYC vehicle | Bausch Health Americas, Inc. | phase 3 | Antiviral agent (topical formulation) | Viral DNA polymerase (via acyclovir active ingredient) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Topical formulation class)
- LEO Pharma · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vehicle gel (SH H 655 PBA) CI watch — RSS
- Vehicle gel (SH H 655 PBA) CI watch — Atom
- Vehicle gel (SH H 655 PBA) CI watch — JSON
- Vehicle gel (SH H 655 PBA) alone — RSS
- Whole Topical formulation class — RSS
Cite this brief
Drug Landscape (2026). Vehicle gel (SH H 655 PBA) — Competitive Intelligence Brief. https://druglandscape.com/ci/vehicle-gel-sh-h-655-pba. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab